Events
AAD 2025 – We’ll meet you there!
Save the date for March 7 to 11 and get ready to launch your path to dermatologic expertise. Delve into an atmosphere of cutting-edge education led by dermatology experts and
more
more
See you in September…at EADV 2024!
The EADV Congress is one of the largest international meetings focused on dermatology and venereology, providing a platform for researchers, clinicians, and industry professionals to exchange knowledge, network, and present their latest research
more
more
News
AAD 2024 in San Diego – What a Show!
As always, the AAD Annual Meeting was a resounding success. The Symbio Proinnovera team was able to meet with many clients and colleagues to discuss innovations in dermatology. It was
more
more
Exciting News From Symbio | Proinnovera
PRESS RELEASE Symbio & Dow Group merges with Proinnovera to form leading dermatology CRO, Symbio Proinnovera New York, USA & Münster, Germany – November 16, 2023 The newly announced merger
more
more
The Symbio Team was at the EADV Congress 2023
It was good to connect with you at The EADV Congress in Berlin. We look forward to seeing you again soon and sharing ideas.
more
more
AAD 2023 – An Event to Remember
Several members of our Symbio staff had the pleasure of attending this year’s AAD conference in New Orleans. It was an amazing opportunity to connect with our clients in person and
more
more
Symbio Releases White Paper: “Atopic Dermatitis – Considerations for Clinical Trials”
The newest white paper in Symbio’s white paper series was recently released entitled, “Atopic Dermatitis: Considerations for Clinical Trials.” This paper explores the clinical research challenges involved in AD trials
more
more
EADV Congress 2022 – a Success for Symbio and Dow
Symbio and Dow Development Laboratories exhibited at EADV Congress 2022 in Milan in September. We met many amazing people and connected with both old friends and new. See you in
more
more
Symbio Releases White Paper: “The Clinical State of Psoriasis”
Symbio has released their latest white paper “The Clinical State of Psoriasis” which aims to explain why biologics have become so popular and why their introduction has been so disruptive
more
more
Success for Symbio at the 2022 AAD Annual Meeting
Symbio and Dow Development Laboratories exhibited at the 2022 AAD Annual Meeting from March 25 to March 29 at the Boston Convention & Exhibition Center in Boston, MA. The event
more
more
Biostatistics for Dermatology Trials – All You Need to Know
White Paper – Derm Trial Statistics
more
more
Phase 3 Dermatology Clinical Trials – All You Need to Know
White Paper – Phase III Trials
more
more
EADV Congress – A Successful Show in Madrid
Symbio and Dow Development Laboratories exhibited at the 28th EADV Congress, “The Modern Face of Dermatology” from October 9 to October 13, 2019 at IFEMA Congress Centre in Madrid, Spain. The
more
more
Success at 2019 AAD Annual Meeting – March 1 to March 5, 2019
Symbio and Dow Development Laboratories were glad to exhibit at the 2019 AAD Annual Meeting from March 1 to March 5, 2019 at the Walter E. Washington Convention Center in
more
more
Symbio Supported the Dermatology Innovation Forum on February 28, 2019
Symbio and Dow Development Laboratories were at the 5th Annual Dermatology Innovation Forum on February 28, 2019 from 8am to 5pm at the Washington Hilton in Washington, DC. As a
more
more
Planning a Clinical Trial in Europe: Which Country to Choose?
Europe may seem small considering only about 10% of the world’s population lives there, but it’s the second largest region by the number of studies conducted according to clinicaltrials.gov. The
more
more
World Congress of Dermatology
Symbio exhibited at the 24th World Congress of Dermatology from June 10 to June 15, 2019 at MiCo – Milano Congressi in Milan, Italy.
more
more